75 related articles for article (PubMed ID: 10994934)
21. Direct coronary stenting versus stenting with balloon pre-dilation: incidence of enzyme release and follow-up results of a multicentre, prospective, randomized study. The CK and Troponin I Estimation in direct STenting (CK TEST) trial.
Balducelli M; Varani E; Vecchi G; Paloscia L; Manari A; Santarelli A; Cappi B; Shoeib A; Valenti S; Maresta A;
Minerva Cardioangiol; 2007 Jun; 55(3):281-9. PubMed ID: 17534246
[TBL] [Abstract][Full Text] [Related]
22. Long-term outcome of patients of over 85 years old with acute coronary syndrome undergoing percutaneous coronary stenting: a comparison of bare metal stent and drug eluting stent.
Ma HY; Zhou YJ; Dick RJ; Shi DM; Liu YY; Cheng WJ; Guo YH; Wang JL; Ge HL
Chin Med J (Engl); 2008 May; 121(10):887-91. PubMed ID: 18706201
[TBL] [Abstract][Full Text] [Related]
23. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
[TBL] [Abstract][Full Text] [Related]
24. A randomized trial of stenting with or without balloon predilation for the treatment of coronary artery disease.
Kovar LI; Monrad ES; Sherman W; Kunchithapatham S; Ravi KL; Gotsis W; Silverman G; Brown DL
Am Heart J; 2001 Nov; 142(5):E9. PubMed ID: 11685184
[TBL] [Abstract][Full Text] [Related]
25. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
[TBL] [Abstract][Full Text] [Related]
26. Outcome of percutaneous hybrid coronary revascularization: bare metal stents jeopardize the benefit of sirolimus-eluting stents in the real world.
Fineschi M; Gori T; Pierli C; Casini S; Sinicropi G; Buti A; Del Pasqua A; Bravi A
Can J Cardiol; 2005 Dec; 21(14):1281-5. PubMed ID: 16341297
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of stenting for unprotected left main coronary artery disease in 297 patients.
Han YL; Wang SL; Jin QM; Liu HW; Ma YY; Wang ZL; Wang DM; Luan B; Wang G
Chin Med J (Engl); 2006 Apr; 119(7):544-50. PubMed ID: 16620694
[TBL] [Abstract][Full Text] [Related]
28. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
29. Prognostic impact of previous percutaneous coronary intervention in patients with diabetes mellitus and triple-vessel disease undergoing coronary artery bypass surgery.
Thielmann M; Neuhäuser M; Knipp S; Kottenberg-Assenmacher E; Marr A; Pizanis N; Hartmann M; Kamler M; Massoudy P; Jakob H
J Thorac Cardiovasc Surg; 2007 Aug; 134(2):470-6. PubMed ID: 17662792
[TBL] [Abstract][Full Text] [Related]
30. Impact of treatment of coronary artery disease with sirolimus-eluting stents on outcomes of diabetic and nondiabetic patients.
Kuchulakanti PK; Torguson R; Canos D; Rha SW; Chu WW; Clavijo L; Deible R; Gevorkian N; Suddath WO; Satler LF; Kent KM; Pichard AD; Waksman R
Am J Cardiol; 2005 Oct; 96(8):1100-6. PubMed ID: 16214445
[TBL] [Abstract][Full Text] [Related]
31. Clinical and angiographic outcome of elective stent implantation in small coronary vessels: an analysis of the BENESTENT trial.
Keane D; Azar AJ; de Jaegere P; Rutsch W; de Bruyne B; Legrand V; Kiemeneij F; de Feyter P; van de Heuvel P; Ozaki Y; Morel MA; Serruys PW
Semin Interv Cardiol; 1996 Dec; 1(4):255-62. PubMed ID: 9552519
[TBL] [Abstract][Full Text] [Related]
32. Differences in outcomes between women and men associated with percutaneous transluminal coronary angioplasty. A regional prospective study of 13,061 procedures. Northern New England Cardiovascular Disease Study Group.
Malenka DJ; O'Connor GT; Quinton H; Wennberg D; Robb JF; Shubrooks S; Kellett MA; Hearne MJ; Bradley WA; VerLee P
Circulation; 1996 Nov; 94(9 Suppl):II99-104. PubMed ID: 8901727
[TBL] [Abstract][Full Text] [Related]
33. Economic outcomes analysis of stenting versus percutaneous transluminal coronary angioplasty for patients with coronary artery disease in Japan.
Ikeda S; Bosch J; Banz K; Schneller P
J Invasive Cardiol; 2000 Apr; 12(4):194-9. PubMed ID: 10785672
[TBL] [Abstract][Full Text] [Related]
34. Adverse events associated with balloon rupture during percutaneous coronary intervention.
Chan AW; Rabinowitz A; Webb JG; Dodek A; Jarochowski M; Lohavanichbutr K; Carere RG
Can J Cardiol; 1999 Sep; 15(9):962-6. PubMed ID: 10504176
[TBL] [Abstract][Full Text] [Related]
35. Acute complications and restenosis in women undergoing percutaneous transluminal coronary angioplasty. Is it possible to define sex differences and to determine risk factors?
Heidland UE; Heintzen MP; Klimek WJ; Michel CJ; Strauer BE
J Cardiovasc Risk; 1998; 5(5-6):297-302. PubMed ID: 9919999
[TBL] [Abstract][Full Text] [Related]
36. [Intracoronary stents in the treatment of angioplasty complications].
Cequier A; Mauri J; Gómez-Hospital JA; Sabaté M; Jara F; Esplugas E
Rev Esp Cardiol; 1997; 50 Suppl 2():21-30. PubMed ID: 9221453
[TBL] [Abstract][Full Text] [Related]
37. Benchmarking cardiac catheterization laboratories: the impact of patient age, gender and risk factors on variable costs, device costs, total time and procedural time in 53 catheterization laboratories.
Becker ER; Cohen D; Culler SD; Ellis S; Green LM; Schnitzler RN; Simon A; Weintraub WS
J Invasive Cardiol; 1999 Sep; 11(9):533-42. PubMed ID: 10745592
[TBL] [Abstract][Full Text] [Related]
38. [De-novo reversible stenoses in tortuous arteries during coronary angioplasty due to the accordion effect. A clinical case and review of the literature].
Gouveia D; Escudero J; Domingo E; Anivarro I; Angel J; Soler JS
Rev Port Cardiol; 1997 Dec; 16(12):1037-42, 957. PubMed ID: 9522627
[TBL] [Abstract][Full Text] [Related]
39. Implications of small reference vessel diameter in patients undergoing percutaneous coronary revascularization.
Schunkert H; Harrell L; Palacios IF
J Am Coll Cardiol; 1999 Jul; 34(1):40-8. PubMed ID: 10399990
[TBL] [Abstract][Full Text] [Related]
40. Patients at high risk for ischemic complications.
Lincoff AM
J Invasive Cardiol; 1994; 6 Suppl A():13A-18A; discussion 50A-51A. PubMed ID: 10155089
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
